Maclean; John

Patent Applications and Registrations

Patent applications and USPTO patent grants for Maclean; John.The latest application filed is for "search and retrieval data processing system for computing near real-time data aggregations".

Company Profile

0.16.13

Maclean; John - Elderslie N/A GB
MacLean; John - Brookline MA
MacLean; John - Melbourne AU
MacLean; John - Kilmarnock N/A GB
MacLean; John - Alexandria KY US
MacLean; John - Kilmamock GB
MacLean; John - US
MacLean; John - Calgary CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Managing queries Grant 10,459,915 - Stanfill , et al. Oc	2019-10-29
Pyrazolopyridyl compounds as aldosterone synthase inhibitors Grant 9,844,553 - Bennett , et al. December 19, 2	2017-12-19
Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease Grant 9,783,511 - Aicher , et al. October 10, 2	2017-10-10
Search And Retrieval Data Processing System For Computing Near Real-time Data Aggregations App 20170177446 - MacLean; John ; et al.	2017-06-22
2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease Grant 9,663,502 - Aicher , et al. May 30, 2	2017-05-30
Triazolopyridyl compounds as aldosterone synthase inhibitors Grant 9,567,333 - Bennett , et al. February 14, 2	2017-02-14
Pyrazolopyridyl Compounds As Aldosterone Synthase Inhibitors App 20170020879 - Bennett; D. Jonathan ; et al.	2017-01-26
Imidazopyridyl compounds as aldosterone synthase inhibitors Grant 9,518,055 - Ali , et al. December 13, 2	2016-12-13
CARBAMATE BENZOXAZINE PROPIONIC ACIDS AND ACID DERIVATIVES FOR MODULATION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE App 20160311787 - Aicher; Thomas D. ; et al.	2016-10-27
2-ACYLAMIDOMETHYL AND SULFONYLAMIDOMETHYL BENZOXAZINE CARBAMATES FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE App 20160304505 - Aicher; Thomas D. ; et al.	2016-10-20
Aldosterone synthase inhibitors Grant 9,382,226 - Hoyt , et al. July 5, 2	2016-07-05
Pyrazolopyridyl compounds as aldosterone synthase inhibitors Grant 9,351,973 - Bennett , et al. May 31, 2	2016-05-31
Triazolopyridyl Compounds As Aldosterone Synthase Inhibitors App 20160039817 - Bennett; D. Jonathan ; et al.	2016-02-11
Imidazopyridyl Compounds As Aldosterone Synthase Inhibitors App 20160031882 - Ali; Amjad ; et al.	2016-02-04
Triazolopyridyl compounds as aldosterone synthase inhibitors Grant 9,193,724 - Bennett , et al. November 24, 2	2015-11-24
Pyrazolopyridyl Compounds As Aldosterone Synthase Inhibitors App 20140288094 - Bennett; D. Jonathan ; et al.	2014-09-25
Triazolopyridyl Compounds As Aldosterone Synthase Inhibitors App 20140228396 - Bennett; D. Jonathan ; et al.	2014-08-14
Document management system for buildings Grant 8,688,755 - Murdock , et al. April 1, 2	2014-04-01
Aldosterone Synthase Inhibitors App 20130317057 - Hoyt; Scott B. ; et al.	2013-11-28
Document Management System for Buildings App 20120239635 - Murdock; Michael ; et al.	2012-09-20
Document management system for building maintenance and operational documents Grant 8,195,723 - Murdock , et al. June 5, 2	2012-06-05
Managing Queries App 20110153662 - Stanfill; Craig W. ; et al.	2011-06-23
Document Management System For Building Maintenance And Operational Documents App 20100010966 - Murdock; Michael ; et al.	2010-01-14
Workpiece locating device Grant 6,042,096 - MacLean March 28, 2	2000-03-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.